CommScope Holding Company, Inc. (COMM) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q3 25	-$0.13	$0.39	+400.0%	—	$1.6B	—
Q2 25	$0.24	$0.44	+83.3%	—	$1.4B	—
Q1 25	-$0.32	$2.88	+1000.0%	—	$1.1B	—
Q4 24	$0.03	$0.18	+500.0%	—	$1.2B	—
Q3 24	$0.3	-$0.05	-116.7%	—	$1.1B	—
Q2 24	—	$0.34	—	—	$1.4B	—
Q1 24	-$0.24	-$0.08	+66.7%	—	$1.2B	—
Q4 23	$0.06	-$0.02	-133.3%	—	$269.8M	—
Q3 23	$0.14	$0.13	-7.1%	—	$1.1B	—
Q2 23	$0.38	$0.19	-50.0%	—	$1.6B	—
Q1 23	$0.35	$0.35	0.0%	—	$1.7B	—
Q4 22	$0.48	$0.49	+2.1%	—	$2.3B	—
Q3 22	$0.46	$0.5	+8.7%	—	$2.4B	—
Q2 22	$0.29	$0.41	+41.4%	—	$2.3B	—
Q1 22	$0.22	$0.26	+18.2%	—	$2.2B	—
Q4 21	$0.17	$0.31	+82.4%	—	$2.2B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$10.1	—	—	$1.9B	—
FY24	—	-$1.78	—	—	$4.2B	—
FY23	—	-$7.17	—	—	$5.8B	—
FY22	—	-$6.49	—	—	$7.5B	—

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$4.9B	$4.6B	$4.6B	$8.3B	$8.4B	$6.7B	$7.5B	$5.8B	$4.2B	$1.9B
YoY change	+29.3%	-7.37%	+0.17%	+82.7%	+1.09%	-20.1%	+11.7%	-23.1%	-27.4%	-54.1%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	4.9B	4.6B	4.6B	8.3B	8.4B	6.7B	7.5B	5.8B	4.2B	1.9B
Cost of revenue	2.9B	2.9B	2.9B	5.9B	5.7B	4.3B	4.9B	3.6B	2.6B	975.7M
Gross profit	2B	1.7B	1.6B	2.4B	2.7B	2.4B	2.6B	2.1B	1.6B	955.9M
Gross margin	41.2%	37.4%	35.8%	28.8%	32.6%	36.2%	34.5%	37.1%	37.5%	49.5%
Research & development	201.3M	185.6M	185.7M	578.5M	703.3M	565M	543.6M	459.7M	316.2M	283.5M
Selling, general & administrative	881.7M	733.1M	674M	1.3B	1.2B	1.1B	1B	873.3M	755.5M	497.4M
Operating expenses	1.1B	918.7M	859.7M	1.9B	1.9B	1.6B	1.6B	1.3B	1.1B	785.7M
Operating income	649.1M	515.8M	509M	-44.7M	243.3M	281.7M	569.5M	488.2M	268.7M	31.8M
Operating margin	13.2%	11.3%	11.1%	-0.54%	2.88%	4.18%	7.57%	8.43%	6.39%	1.65%
Non-operating income, net	-104.5M	-53.2M	-103.3M	-470.2M	-324.4M	-111.6M	-1.2B	-541.4M	-2M	6.4M
Pretax income	272.6M	209.8M	170.7M	-1.1B	-654.5M	-389.2M	-1.2B	-717.9M	-409.3M	54.9M
Income tax	49.7M	16M	30.5M	-144.5M	-81.1M	-39.2M	-15M	133.4M	51.7M	-269.4M
Net income	222.8M	193.8M	140.2M	-929.5M	-573.4M	-462.6M	-1.3B	-1.5B	-315.5M	2.3B
Net margin	4.53%	4.25%	3.07%	-11.1%	-6.8%	-6.87%	-17.1%	-25.1%	-7.5%	118.2%
EBITDA	1B	888.6M	829.2M	737.9M	1B	1B	1.3B	1.1B	660.3M	293M
EPS	1.16	1.01	0.73	-5.02	-3.2	-2.55	-6.49	-7.17	-1.78	10.1
Diluted EPS	1.13	0.98	0.72	-5.02	-3.2	-2.55	-6.49	-7.17	-1.78	9.63

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25
Revenue	1.7B	1.6B	1.1B	269.8M	1.2B	1.4B	1.1B	1.2B	1.1B	1.4B	1.6B	-2.2B
Cost of revenue	1B	1B	673.2M	-23.4M	766.2M	839.3M	647.1M	719M	643.6M	796.4M	961.9M	-1.4B
Gross profit	630.2M	568.9M	380.2M	293.2M	402.2M	547.6M	435.1M	450.1M	468.6M	591.7M	667.8M	-772.2M
Gross margin	37.9%	35.8%	36.1%	108.7%	34.4%	39.5%	40.2%	38.5%	42.1%	42.6%	41%	35.1%
Research & development	125.6M	128.3M	85.4M	27.6M	104.4M	91.6M	78M	81M	83.9M	90.9M	95.3M	13.4M
Selling, general & administrative	232M	230M	186.4M	125.2M	199.7M	210.3M	203.4M	190M	194.2M	215.6M	226.8M	-139.2M
Operating expenses	357.6M	358.3M	271.8M	152.8M	304.1M	301.9M	281.4M	271M	278.1M	311.4M	322M	-125.8M
Operating income	172M	134.8M	39.5M	142.4M	23.9M	185.3M	96.9M	124M	136.5M	228.7M	294.1M	-627.5M
Operating margin	10.3%	8.48%	3.75%	52.8%	2.05%	13.4%	8.95%	10.6%	12.3%	16.5%	18%	28.5%
Non-operating income, net	16.4M	-34.9M	-439.9M	391M	-22.1M	11.2M	-1.5M	4.5M	-11.6M	-4.9M	6.1M	16.8M
Pretax income	25.8M	-66.7M	-568.3M	365.8M	-162.3M	31.1M	-70M	-52.6M	-44.4M	70.8M	149.5M	-121M
Income tax	-4M	-3.6M	-34.5M	291.4M	99.8M	-43.7M	26.7M	10.5M	-334.1M	41.4M	42.6M	-19.3M
Net income	3.4M	-100.4M	-828.7M	-525.2M	-359.2M	44.4M	-33M	32.3M	784M	31.8M	108.4M	1.4B
Net margin	0.2%	-6.32%	-78.7%	-194.7%	-30.7%	3.2%	-3.05%	2.76%	70.5%	2.29%	6.65%	-61.8%
EBITDA	345.6M	279.4M	190.1M	305.6M	139.9M	280.6M	188.1M	213.1M	217.7M	306.5M	373.1M	-604.3M
EPS	-0.06	-0.55	-3.98	—	-1.77	0.13	-0.23	-0.05	3.55	0.07	0.41	6.05
Diluted EPS	-0.06	-0.55	-3.98	—	-1.77	0.13	-0.23	-0.05	2.88	0.06	0.39	6.05

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	—	—	—	—	—	—	—	—	1.3B
Enterprise value	—	—	—	—	—	—	—	—	—	—	12.3B
Shares outstanding	192.5M	192.4M	192M	193.7M	196.8M	203.6M	207.4M	210.9M	214.4M	219.5M	219.5M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	—	—	—	—	—	—	16.7
P/S	—	—	—	—	—	—	—	—	—	—	0.82
P/B	—	—	—	—	—	—	—	—	—	—	4.92
EV/EBITDA	—	—	—	—	—	—	—	—	—	—	10.3
EV/Sales	—	—	—	—	—	—	—	—	—	—	2.32
Earnings yield	—	—	—	—	—	—	—	—	—	—	5.98%
FCF yield	—	—	—	—	—	—	—	—	—	—	108.4%
PEG	—	—	—	—	—	—	—	—	—	—	-0

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	41.2%	37.4%	35.8%	28.8%	32.6%	36.2%	34.5%	37.1%	37.5%	49.5%	35.1%
Operating margin	13.2%	11.3%	11.1%	-0.54%	2.88%	4.18%	7.57%	8.43%	6.39%	1.65%	19.8%
Net margin	4.53%	4.25%	3.07%	-11.1%	-6.8%	-6.87%	-17.1%	-25.1%	-7.5%	118.2%	17.6%
ROE	16%	11.8%	7.98%	-50.6%	-41.1%	-51.4%	288.7%	80.3%	14.2%	831.6%	806.6%
ROA	3.12%	2.75%	2.11%	-6.44%	-4.22%	-3.49%	-11%	-15.5%	-3.61%	24.4%	6.61%
ROIC	9.6%	8.56%	7.91%	-0.4%	2.33%	2.79%	6.53%	7.01%	4.15%	0.47%	0.47%
Return on tangible assets	-11.2%	-9.67%	-7.88%	18.4%	13.3%	14.2%	444.4%	176.4%	-54.3%	37.1%	37.1%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	2.32	2.69	2.72	1.72	1.72	1.64	1.77	2.03	2.83	3.88	2.25
Quick ratio	1.77	2.07	2.03	1.24	1.16	0.98	1.12	1.27	2.23	3.67	3.67
Debt / equity	3.27	2.65	2.27	5.39	6.86	10.6	-21.4	-5.16	-4.16	26.5	0.27
Debt / assets	0.64	0.62	0.6	0.69	0.71	0.72	0.82	0.99	1.06	0.78	0.78
Net debt / EBITDA	4.01	4.41	4.25	12.6	8.7	8.81	7.23	7.83	13.2	22.3	22.3
Interest coverage	1.98	1.82	1.71	-0.86	-0.13	0.31	-1.04	-0.06	0.4	—	—
Effective tax rate	18.2%	7.63%	17.9%	0%	0%	0%	0%	0%	0%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	25.6	23.7	23.8	43.1	42.9	33.1	36.3	27.4	19.6	8.8	24.3
EPS (basic)	1.16	1.01	0.73	-5.02	-3.2	-2.55	-6.49	-7.17	-1.78	10.1	10.1
EPS (diluted)	1.13	0.98	0.72	-5.02	-3.2	-2.55	-6.49	-7.17	-1.78	9.63	1.17
Book value per share	7.24	8.56	9.15	9.48	7.1	4.42	-2.15	-8.57	-10.4	1.25	-10.6
FCF per share	2.97	2.69	2.14	2.54	1.6	-0.04	0.43	1.12	1.16	1.15	1.14
Cash per share	2.22	2.36	2.39	3.09	2.65	1.77	1.8	2.58	2.63	3.44	3.18
Capex per share	0.33	0.33	0.36	0.53	0.59	0.58	0.49	0.08	0.12	0.27	0.27

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	1.3%	1.39%	1.52%	1.23%	1.38%	1.76%	1.34%	0.31%	0.6%	3.12%	3.12%
Capex / operating cash flow	11.7%	10.7%	16.7%	40.4%	42.8%	112.2%	-10.5%	-7.18%	15.1%	-502.5%	63.3%
Payout ratio	—	0%	0%	-4.7%	-2.49%	-9.3%	-1.16%	0%	0%	0.77%	0%

Period	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25
Revenue	$1.7B	$1.6B	$1.1B	$269.8M	$1.2B	$1.4B	$1.1B	$1.2B	$1.1B	$1.4B	$1.6B	-$2.2B
YoY change	-25.3%	-30.9%	-55.8%	-88.4%	-29.8%	-12.7%	+2.73%	+333.3%	-4.81%	+0.09%	+50.6%	-288%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	428.2M	454M	458.2M	598.2M	521.9M	360.3M	373M	543.8M	564.9M	754.4M
Receivables	952.4M	898.8M	810.4M	1.7B	1.5B	1.5B	1.2B	815.2M	685.9M	350.4M
Inventory	473.3M	444.9M	473.3M	975.9M	1.1B	1.4B	1.4B	1.1B	736.8M	310.4M
Total current assets	2B	1.9B	1.9B	3.5B	3.4B	3.6B	3.7B	2.9B	3.5B	5.8B
Property, plant & equipment	266.5M	249.9M	238.7M	390.5M	344.7M	321.9M	261.5M	187M	129.1M	-17.6M
Goodwill & intangibles	9.1B	9B	8.4B	19.5B	17.9B	16.5B	12B	10.2B	8.2B	3.2B
Total assets	7.1B	7B	6.6B	14.4B	13.6B	13.3B	11.7B	9.4B	8.7B	9.4B
Accounts payable	415.9M	436.7M	399.2M	1.1B	1B	1.2B	684.3M	435.9M	370.7M	213.3M
Short-term debt	12.5M	—	—	93.7M	94.4M	78.7M	76.4M	68.5M	33.7M	13.9M
Total current liabilities	857.8M	723.7M	690.6M	2B	2B	2.2B	2.1B	1.4B	1.2B	1.5B
Long-term debt	4.5B	4.4B	4B	9.8B	9.5B	9.5B	9.5B	9.2B	9.2B	7.3B
Total liabilities	5.7B	5.4B	4.9B	12.6B	12.2B	12.4B	12.1B	11.2B	11B	9.1B
Shareholders' equity	1.4B	1.6B	1.8B	1.8B	1.4B	899.5M	-445.7M	-1.8B	-2.2B	274.6M
Total debt	4.6B	4.4B	4B	9.9B	9.6B	9.6B	9.5B	9.3B	9.3B	7.3B
Net debt	4.1B	3.9B	3.5B	9.3B	9.1B	9.2B	9.2B	8.8B	8.7B	6.5B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25
Cash & short-term investments	327.3M	418.1M	518.9M	543.8M	357.2M	345.9M	392.1M	564.9M	493.3M	571.1M	705.3M	754.4M
Receivables	1.4B	1.4B	1.2B	815.2M	854.2M	999M	674.8M	685.9M	844.3M	935.1M	1B	350.4M
Inventory	1.6B	1.5B	1.4B	1.1B	1B	1B	843.5M	736.8M	765.7M	822.8M	798.4M	310.4M
Total current assets	3.5B	3.4B	3.2B	2.9B	2.4B	2.6B	3.4B	3.5B	2.3B	2.5B	2.8B	5.8B
Property, plant & equipment	-905.8M	733.9M	706.6M	187M	-880.9M	-890.9M	-757.5M	129.1M	—	-719.5M	-721.6M	-17.6M
Goodwill & intangibles	12.9B	12.7B	10.6B	10.2B	10B	9.9B	8.4B	8.2B	8.1B	8.1B	8B	3.2B
Total assets	11.3B	11.2B	10.1B	9.4B	8.7B	8.8B	8.8B	8.7B	7.5B	7.7B	7.9B	9.4B
Accounts payable	905.4M	782.7M	795.3M	435.9M	454.6M	494.8M	381.7M	370.7M	467.5M	531.2M	592.5M	213.3M
Short-term debt	79.3M	77.3M	72.9M	68.5M	68.8M	1.3B	1.3B	33.7M	32.1M	32.8M	30.7M	13.9M
Total current liabilities	1.8B	1.7B	1.5B	1.4B	1B	2.5B	2.5B	1.2B	1B	1.2B	1.2B	1.5B
Long-term debt	9.4B	9.5B	9.5B	9.2B	9.2B	8B	8B	9.2B	7.2B	7.2B	7.3B	7.3B
Total liabilities	11.8B	11.7B	11.4B	11.2B	10.8B	10.9B	10.9B	11B	8.8B	8.9B	9B	9.1B
Shareholders' equity	-415M	-485.1M	-1.3B	-1.8B	-2.2B	-2.1B	-2.1B	-2.2B	-1.3B	-1.2B	-1.1B	274.6M
Total debt	9.5B	9.6B	9.6B	9.3B	9.3B	9.3B	9.3B	9.3B	7.3B	7.3B	7.3B	7.3B
Net debt	9.2B	9.2B	9.1B	8.8B	9B	9B	8.9B	8.7B	6.8B	6.7B	6.6B	6.5B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	222.8M	193.8M	140.2M	-929.5M	-573.4M	-462.6M	-1.3B	-1.5B	-315.5M	2.3B
Depreciation & amortization	399.1M	378M	357.5M	770.9M	823.3M	786.3M	696.1M	561.2M	370.5M	277M
Stock-based compensation	35M	41.8M	44.9M	90.8M	115M	79.6M	61.1M	47.3M	29.1M	42.7M
Change in working capital	-17M	8.1M	-109.4M	580.3M	2.3M	-200.5M	-318.6M	880.6M	-23.8M	-460.1M
Operating cash flow	549.6M	593.8M	415.5M	254M	271.5M	105.4M	-960.5M	-249.2M	166.3M	-12M
Capital expenditure	-64.2M	-63.3M	-69.4M	-102.5M	-116.2M	-118.3M	-101.2M	17.9M	-25.1M	-60.3M
Investing cash flow	-54.6M	-166.2M	-64.3M	-5.2B	-120.2M	-136.8M	-82.1M	38.3M	-57.2M	2B
Dividends paid	—	0	0	-43.7M	-14.3M	-43M	-14.9M	0	0	-17.6M
Share repurchases	0	-175M	0	0	—	—	—	—	—	—
Financing cash flow	-725.1M	-423.6M	-415.7M	4.7B	-392.8M	-145.1M	-65M	-181.7M	-83M	-2.1B
Net change in cash	-230.1M	4M	-64.5M	-206.9M	-241.5M	-176.5M	-1.1B	-392.6M	26.1M	-84M
Free cash flow	571.9M	517.6M	411.8M	492.3M	315M	-9.1M	88.7M	236.6M	247.8M	252.6M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25
Net income	3.4M	-100.4M	-828.7M	-525.2M	-359.2M	44.4M	-58.5M	32.3M	784M	31.8M	108.4M	1.4B
Depreciation & amortization	164.1M	139.4M	138.7M	119M	112.7M	89.8M	85.2M	82.8M	78M	75.2M	74.7M	49.1M
Stock-based compensation	13.5M	10.7M	11.3M	11.8M	11.2M	1.6M	8.3M	8M	7.5M	9.1M	10.7M	15.4M
Change in working capital	-174.9M	73.7M	169.4M	260M	-15.3M	-1.1M	67.5M	55.8M	-165.3M	-142.7M	-86.3M	41.5M
Operating cash flow	-56.3M	130.7M	-753.2M	-122.8M	-105.8M	63.3M	141.2M	200.1M	-137.9M	-1.2M	141.9M	92.5M
Capital expenditure	26.6M	-20.2M	-8.5M	20M	-6M	-5.1M	-6.7M	-7.3M	-15.5M	-2.6M	-16.4M	-25.8M
Investing cash flow	35.9M	-9M	-8.6M	20M	2.6M	-5.1M	-6.7M	-2.9M	2B	-2.6M	-16.3M	-25.8M
Dividends paid	—	—	—	0	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-61.1M	-36.7M	-25.1M	-58.8M	-8.2M	-9.6M	-8M	-4.4B	-2B	-9.4M	-300K	-20.1M
Net change in cash	-81.5M	85M	-786.9M	-161.6M	-111.4M	48.6M	126.5M	-4.2B	-125.1M	-13.2M	125.3M	46.6M
Free cash flow	-60.5M	116M	130.1M	51M	-183.7M	45.5M	115.4M	270.6M	-202.4M	64.5M	135M	255.5M

CommScope Holding Company, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement